Close
Nordic 9Nordic 9

Nara Capital (investor - Venture Capital)

Spain nara.capital
See something wrong or missing? Let us know
Offices:Barcelona

Nara Capital is an investment firm from Spain that invests in biotech & life sciences SMEs and startups.

  • in 2024, Nara Capital has also launched a fund of funds, in partnership with Plug and Play, called Nara Ventures, at ​€100 million​.
Average round investment:5.86M USD
Average number per year:2.5
Distribution: 2025 (1)2023 (4)
Portfolio companies: Spain AortyxSpain mimarkSpain OneChain Immunotherapeutics See the entire list
Mostly invests in: Spain Spain (5) Manufacturing (4)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Nara Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Nara Capital

Name Criteria
France Impactivist
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States Ataraxia
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain GAEA Inversion
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Fifty Years
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Advent France Biotechnology
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Shio Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 4.4
  • Active last 12 months: Yes
United States Expa
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Germany Trumpf Venture
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Spain ICF Capital
82%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Spain Cleon Capital
81%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Manufacturing, Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: Spain
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top